ARCHIVES

In Vote Against Tarceva As Maintenance, ODAC Seeks Stronger Survival Benefit

This article is from The Cancer Letter archive.

Vol. 35 No. 46 | December 18, 2009

Download PDF Visit The Full Archive

Related Articles

Data collection Completed In NCI Study of BRACA1

August 16, 1996

Von Eschenbach Says He Will Step Down as NCI Director; No Acting Director Has Been Named.

March 24, 2006

Post-Hoc Analysis of ThermoDox Suggests OS Improvement

January 31, 2014

U.S. Cigarette Sales Dropped 4.2 Percent Last Year

March 31, 2006

In Brief: First CREG Announcement Due In Late April For In Vitro Carcinogen Test Improvements

March 21, 1975

An Appreciation: Eddie Reed, 60, a Developer of Taxol

June 6, 2014